Tecartus®
Company
Kite Pharma
Use
Treatment of mantle cell lymphoma and B-cell precursor acute lymphoblastic leukemia.
Features
CD19-directed CAR T-cell immunotherapy.
NIH Contribution
CAR T-cell technology research: Enhancing T-cell therapy efficacy
HHS Institute/Agency
NCI
Inventor(s)
Kochenderfer, J. et al.
Year
2020
